Phillip B. Donenberg
Independent DirectorMr. Phillip B. Donenberg, also known as Phil, CPA, is Independent Director at Faeth Therapeutics, Inc. (formerly known as Sensei Biotherapeutics, Inc.) since February 13, 2026. He is Independent Director of Tectonic Therapeutic, Inc since June 2024. He had been Senior Vice President and Chief Financial Officer of Jaguar Gene Therapy, LLC from February 2020 to March 2023. Mr. Donenberg has been Independent Director at Taysha Gene Therapies, Inc since August 2020. Mr. Donenberg served as Chief Financial Officer and Senior Vice President of Assertio Therapeutics, Inc., a pharmaceutical company, from July 2018 to November 2018. He was Chief Financial Officer and Senior Vice President at DepoMed Inc. since July 16, 2018 until November 30, 2018. Mr. Donenberg served as Senior Vice President, Chief Financial Officer and Principal Accounting Officer at AveXis, Inc. since October 19, 2017 until June 2018. Mr. Donenberg served as AveXis’ Vice President, Corporate Controller from September 2016 to October 2017. He served as the Chief Financial Officer and Secretary of Restorgenex Corporation from May 27, 2014 to January 8, 2016 and January 19, 2015 to January 8, 2016 respectively. He served as the Chief Financial Officer of EosHealth, Inc. since October 2013. He served as Chief Financial Officer of Diffusion Pharmaceuticals Inc. until January 08, 2016. He served as Chief Financial Officer, Senior Vice President of Finance and Secretary at ANI Pharmaceuticals, Inc. until June 19, 2013. He served as Chief Financial Officer, Senior Vice President of Finance and Secretary of NI Pharmaceuticals, Inc. since 2010 until June 19, 2013. He served as the Chief Financial Officer of 7wire Ventures LLC from September 2013 to May 2014. He served as the Chief Financial Officer and Secretary of Biosante Pharmaceuticals, Inc. since July 1998 until June 19, 2013 and served as its Principal Accounting Officer. He served as Senior Vice President of Finance at BioSante Pharmaceuticals, Inc. since August 2010. He served as Treasurer of Biosante Pharmaceuticals Inc. from July 1998 to September 2010. Before Biosante Pharma, he served as Controller of Unimed Pharmaceuticals, Inc. from January 1995 to July 1998. Prior to Unimed Pharmaceuticals, Inc. He held similar positions with other pharmaceutical companies, including Gynex Pharmaceuticals, Inc. (currently Savient Pharmaceuticals, Inc.), Applied NeuroSolutions, Inc. (formerly, Molecular Geriatrics Corporation) and Xtramedics, Inc. Mr. Donenberg has been Director of AVROBIO, Inc., a gene therapy company, since June 2018. He earned his BS in Accountancy from the University of Illinois Champaign-Urbana College of Business from 1978 to 1982 and is a Certified Public Accountant.
Positions
- Company NameFaeth Therapeutics, Inc.Stock CodeFTHPositionIndependent DirectorColleagues
- JCJosiah CraverSenior VP of Finance, Principal Financial Officer & Principal Accounting Officer
- APAnand ParikhCEO, President & Chair
- CWChristopher W. GerryGeneral Counsel & Secretary
- SMSiddhartha MukherjeeScientific Co-Founder
- LCLewis clayton CantleyScientific Co-Founder
- KHKaren H. VousdenScientific Co-Founder & Director
- RHRobert HolmenIndependent Director
- PBPhillip B. DonenbergIndependent Director
- SSSona Saira Gonsalves RamasastryDirector
- Company NameTaysha Gene Therapies, Inc.Stock CodeTSHAPositionIndependent DirectorColleagues
- SPSean P. NolanCEO & Chairman
- SNSukumar NagendranPresident, Head of Research & Development and Director
- KAKamran AlamCFO & Corporate Secretary
- HCHayleigh CollinsDirector of Corporate Communications & Investor Relations
- MBMichael B. JohannesenChief Legal Officer & Corporate Secretary
- LSLaura Sepp-LorenzinoIndependent Director
- SSSean StalfortIndependent Director
- Company NameTectonic Therapeutic, Inc.Stock CodeTECXPositionIndependent DirectorColleagues
- ASAlise S. ReicinPresident, CEO, Secretary & Director
- FNFrancois NaderIndependent Chair of the Board
- DLDaniel LochnerChief Financial Officer
- MKMarcella Kuhlman RuddyChief Medical Officer
- WAWashington AlvesSenior Vice President of Technical Operations
- PMPeter McNamaraChief Scientific Officer
- TATimothy A. SpringerIndependent Director
- PPPraveen P. TipirneniIndependent Director
- PBPhillip B. DonenbergIndependent Director
